Breaking news

IEA Lowers 2025 Oil Demand Forecasts Amid Energy Transition And Economic Uncertainty

The International Energy Agency (IEA) has recently revised its global oil demand forecasts downward for 2025, reflecting the complex interplay of evolving energy markets, economic conditions, and accelerating climate initiatives. This adjustment signals a significant shift in the global energy landscape, as nations and industries increasingly pivot towards more sustainable and renewable energy sources.

The ongoing global energy transition is one of the primary drivers behind the IEA’s updated forecast. As governments worldwide implement stricter environmental regulations and invest heavily in renewable energy infrastructure, the demand for fossil fuels, including oil, is expected to diminish. The push towards electrification, particularly in the transportation sector, is a key factor in reducing future oil consumption. The rise of electric vehicles (EVs) and advancements in battery technology are set to reduce reliance on traditional oil-based fuels, contributing to a slower growth rate in oil demand.

Moreover, economic factors play a crucial role in shaping the IEA’s outlook. The global economy, still recovering from the impacts of the COVID-19 pandemic, faces new challenges, including inflationary pressures and geopolitical tensions. These issues are creating an environment of uncertainty, dampening investment in oil-dependent industries and potentially slowing economic growth, which in turn affects oil demand.

The IEA’s revised forecast also takes into account the potential for structural changes in energy consumption patterns. As digitalisation and energy efficiency measures become more widespread, industries are likely to reduce their energy intensity, further curbing the oil demand. Additionally, the ongoing shift in consumer behaviour towards sustainability is expected to drive down demand in sectors traditionally reliant on oil.

Despite these downward revisions, the oil industry is not expected to disappear overnight. Oil will continue to play a significant role in the global energy mix for years to come, particularly in sectors where alternatives are not yet economically viable. However, the IEA’s updated forecasts highlight the need for oil producers to adapt to a rapidly changing market, where demand growth is no longer guaranteed.

Medochemie And Theramir Announce Strategic Investment Agreement To Advance Biotech Manufacturing In Cyprus

Pharmaceutical manufacturer Medochemie and biotechnology company Theramir, both Cyprus-based, have announced a strategic investment agreement and collaboration aimed at developing next-generation biological therapies and expanding manufacturing capabilities in Cyprus.

The agreement, announced on 2 September 2026, brings together Medochemie’s experience in pharmaceutical manufacturing and Theramir’s biotechnology research. The companies said the collaboration would support advanced pharmaceutical manufacturing in Cyprus and south-eastern Europe.

What The Partnership Covers

Medochemie’s contribution will include its expertise in manufacturing sterile therapeutic products and its access to international markets.

Theramir develops technologies based on extracellular vesicles and microRNAs. Its work includes using stem-cell-derived extracellular vesicles to deliver microRNAs, small, non-coding RNA molecules that regulate genes and biological pathways associated with cancer growth and metastasis.

Under the agreement, the companies will jointly support the development of “Good Manufacturing Practice” capabilities for next-generation biological therapies. The partnership is also intended to help move these therapies towards clinical development.

A Wider Role For Cyprus

The collaboration will also support Theramir’s wider research programme. According to the companies, it is intended to strengthen Cyprus’s biotechnology infrastructure and expand local capacity in next-generation biomanufacturing.

They present the agreement as a step towards giving Cyprus a larger role in biotechnology and advanced pharmaceutical manufacturing for south-eastern Europe and international markets.

The Future Forbes Realty Global Properties
Uol
Aretilaw firm
eCredo

Become a Speaker

Become a Speaker

Become a Partner

Subscribe for our weekly newsletter